PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. Electronic address: john.sapp@nshealth.ca.\', \'University of Ottawa Heart Institute, Ottawa, Ontario, Canada.\', \'Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.\', \'Cardiovascular Genetics Centre, Montréal Heart Institute, Montréal, Québec, Canada.\', \'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, Québec, Canada.\', \'Western University, London, Ontario, Canada.\', \'University of British Columbia, Vancouver, British Columbia, Canada.\', \'Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0828-282X(20)30325-110.1016/j.cjca.2020.04.003
?:doi
?:hasPublicationType
?:journal
  • The Canadian journal of cardiology
is ?:pmid of
?:pmid
?:pmid
  • 32299753
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32299753>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32299753>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all